Performance of the Lausanne questionnaire and the 2010 European Society of Cardiology criteria for ECG interpretation in athletes

Snoek, Johan A.; Jongman, J. K.; Brandon, Tom; Berkel, Sietske van; Hof, Arnoud W.J. van’t

doi:10.1177/2047487313506827

Cited by 11 publications

(3 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The mean age per article varied from 12.4 to 54.6 years. Twenty‐eight articles comprised 59 685 athletes aged ≤35 years (74.5%), 16–44 of which seven articles reported findings in 18 535 athletes ≤18 years 16–23 . Thirty‐one articles reported gender (79619), of which four included men only 25,28,42,44 .…”

Section: Resultsmentioning

confidence: 99%

“…The most used referenced standard for H-PE screening was from the 2007 American Heart Association recommendations (n = 12), 20,25,[28][29][30]34,36,38,41,43,47,49 and for ECG assessment from the 2010 European Society of Cardiology (n = 13) 18,21,23,25,26,32,35,36,[38][39][40][41]43,44 and 2013 Seattle criteria (n = 12). 19,25,28,32,[24][25][26][27][28][29][30][31][32][33][34][35][36]39,41,45,47,48 Ten articles used two or more referenced standards for ECG assessment.…”

Section: Methodological Qualitymentioning

confidence: 99%

“…Twenty-eight articles had study design limitations leading to further downgrading of the quality of evidence (Supplementary file 3). According to GRADE, quality of evidence of athlete screening was 'very low' for all articles, of which three articles were downgraded observational studies, 34,40,43,47 and 30 articles double downgraded by ≥2 factors (Figure 2). We found no difference in quality of evidence rating between prospective and retrospective studies, nor between larger or smaller studies.…”

Section: Quality Of Evidencementioning

confidence: 99%

See 2 more Smart Citations

Quality of athlete screening for high‐risk cardiovascular conditions—A systematic review

Panhuyzen‐Goedkoop,

Verbeek,

Goedkoop

et al. 2023

Scandinavian Med Sci Sports

View full text Add to dashboard Cite

BackgroundSudden cardiac death (SCD) is the leading medical cause of death in athletes. To prevent SCD, screening for high‐risk cardiovascular conditions (HRCC) is recommended. Screening strategies are based on a limited number of studies and expert consensus. However, evidence and efficacy of athlete HRCC screening is unclear.ObjectiveTo determine methodological quality and quality of evidence of athlete screening, and screening efficacy to detect HRCC in a systematic review.MethodsWe performed a systematic search of Medline, Embase, Scopus and Cochrane Library up to June 2021. We included articles containing original data of athlete cardiovascular screening, providing details of screening strategies, test results and HRCC detection. We assessed methodological quality of the included articles by QUADAS‐2, quality of evidence of athlete HRCC screening by GRADE, and athlete HRCC screening efficacy by SWiM.ResultsOf 2720 citations, we included 33 articles (1991–2018), comprising 82 417 athletes (26.7% elite, 73.4% competitive, 21.7% women, 75.2% aged ≤35). Methodological quality was ‘very low’ (33 articles), caused by absence of data blinding and inappropriate statistical analysis. Quality of evidence was ‘very low’ (33 articles), due to observational designs and population heterogeneity. Screening efficacy could not be reliably established. The prevalence of HRCC was 0.43% with false positive rate (FPR) 13.0%.ConclusionsMethodological quality and quality of evidence on athlete screening are suboptimal. Efficacy could not be reliably established. The prevalence of screen detected HRCC was very low and FPR high. Given the limitations of the evidence, individual recommendations need to be prudent.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Methodological Qualitymentioning

confidence: 99%

Section: Quality Of Evidencementioning

confidence: 99%

See 1 more Smart Citation

Quality of athlete screening for high‐risk cardiovascular conditions—A systematic review

Panhuyzen‐Goedkoop,

Verbeek,

Goedkoop

et al. 2023

Scandinavian Med Sci Sports

View full text Add to dashboard Cite

show abstract

The Impending Dilemma of Electrocardiogram Screening in Athletic Children

et al. 2015

View full text Add to dashboard Cite

Sudden cardiac death (SCD) affects 2/100,000 young, active athletes per year of which 40% are less than 18 years old. In 2004, the International Olympic Committee accepted the Lausanne Recommendations, including a 12-lead electrocardiogram (ECG), as a pre-participation screening tool for adult Olympic athletes. The debate on extending those recommendations to the pediatric population has recently begun. The aims of our study were to highlight the characteristics of the young athlete ECG, phenotypical manifestations of SCD-related disease in children, and challenges of implanting ECG screening in athletic children. A systematic review of the literature is performed. We searched available electronic medical databases for articles relevant to SCD, ECG, silent cardiac diseases, and athletic children. We focused on ECG screening and description in a pediatric population. We identified 2240 studies. Sixty-two relevant articles and one book were selected. In children, prepubertal ECG and the ECG phenotype of most SCD-related diseases differ notably from adults. The characteristics of the prepubertal ECG and of the phenotypical manifestation of SCD-related disease in children will result in less specific and less sensitive ECG-based screening programs. Those limitations advise against extending the adult recommendation to children, without further studies. Until then, history and physical exam should remain the cornerstone of screening for SCD-related pathologies in children.

show abstract

Pre-participation Cardiovascular Screening in Young Competitive Athletes

Petek

Baggish

2020

Curr Emerg Hosp Med Rep

View full text Add to dashboard Cite

Performance of the Lausanne questionnaire and the 2010 European Society of Cardiology criteria for ECG interpretation in athletes

Cited by 11 publications

References 35 publications

Quality of athlete screening for high‐risk cardiovascular conditions—A systematic review

Quality of athlete screening for high‐risk cardiovascular conditions—A systematic review

The Impending Dilemma of Electrocardiogram Screening in Athletic Children

Pre-participation Cardiovascular Screening in Young Competitive Athletes

Contact Info

Product

Resources

About